Bharat Biotech s Covaxin recommended by expert panel for phase II / III trials on 2-18 year-olds
The trial will take place in 525 subjects at various sites, including AIIMS, Delhi, AIIMS, Patna and Meditrina Institute of Medical Sciences, Nagpur.
Share Via Email
| A+A A- By PTI
NEW DELHI:
Bharat Biotech s COVID-19 vaccine Covaxin was on Tuesday recommended by an expert panel for phase II/III clinical trial on those aged between two to 18 years, official sources said.
The trial will take place in 525 subjects at various sites, including AIIMS, Delhi, AIIMS, Patna and Meditrina Institute of Medical Sciences, Nagpur.
The Subject Expert Committee (SEC) on COVID-19 of the Central Drugs Standard Control Organization (CDSCO) on Tuesday deliberated upon Hyderabad-based Bharat Biotech s application seeking permission to conduct phase II/III clinical trials to evaluate the safety, reactogenicity and immunogenicity of Covaxin jabs in children aged 2 to 18 years.
Second COVID wave in India seems to have flattened but won t end before July: Virologist
According to the scientist, COVID-19 cases in the second wave also won t come down in as steady a fashion as they did after the first wave.
Share Via Email
| A+A A-
A health worker helps a patient after she recovered from COVID-19, during her discharge from State Government run Covid hospital in Kolkata. (Photo | PTI) By PTI
NEW DELHI: India s second COVID-19 wave seems to have flattened but the climb down will be a more prolonged, long drawn-out process than the first and will possibly run till July, eminent virologist Shahid Jameel said here on Tuesday.
COVID-19: Bharat Biotech s Covaxin approved by Centre for children above 12 years? Government said THIS
The tweet shared by PIB also shared a screenshot of the news that claimed that Covaxin has been approved for children. Representational image. , File Photo
Updated: May 10, 2021, 11:16 AM IST
The Centre has refuted reports that claimed the government has approved Bharat Biotech s Covaxin for children above the age of 12.
In ongoing India s vaccination drive, Covaxin is among the vaccines approved by India s drug regulator for emergency use and is being administered to the public.
Busting the rumour, the Press Information Bureau (PIB) tweeted from its fact check account saying, A tweet has claimed that Bharat Biotech s vaccine, Covaxin, has been approved for children above 12 years. #PIBFactCheck: This claim is #Fake. No such approval has been given by the Government of India. Currently, citizens above the age of 18 are eligible for #COVID19Vacc
Battling severe vaccine shortage, the Jharkhand government hit out at the Centre and alleged that it was indulging in politics by not providing the required doses to the state.
Jharkhand has already put on hold the vaccination programme for the 18-44 age group, stating that it will announce the dates for starting the drive once vaccines are made available. The Government of India is indulging in politics with us. As a central government, it should respect the federal structure and facilitate quick delivery of vaccines and medicines to us, state Health Minister Banna Gupta told PTI. We have placed an order for 50 lakh doses. They (Centre) are saying that it will be supplied between May 15 to May 30. How can we start the drive for 18-plus under such circumstances? he added.
Jharkhand has already put on hold the vaccination programme for the 18-44 age group, stating that it will announce the dates for starting the drive once vaccines are made available.
RANCHI: Battling severe vaccine shortage, the Jharkhand government hit out at the Centre and alleged that it was indulging in politics by not providing the required doses to the state.
Jharkhand has already put on hold the vaccination programme for the 18-44 age group, stating that it will announce the dates for starting the drive once vaccines are made available. The Government of India is indulging in politics with us. As a central government, it should respect the federal structure and facilitate quick delivery of vaccines and medicines to us, state health minister Banna Gupta said.